Natural history and prognosis of advanced lung disease

Clinics in Chest Medicine

Volumn 18, Issue 3, 1997, Pages 435-455

  Manaker, S ^a   Tino, G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; HUMAN; HYPERCAPNIA; HYPOXEMIA; LUNG DISEASE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; RISK ASSESSMENT;

EID: 0030868470     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70393-2     Document Type: Article

References (162)

1. N.R. Anthonisen Prognosis in chronic obstructive pulmonary disease: Results from multicenter clinical trials Am Rev Respir Dis 140 1989 S95 S99
2. N.R. Anthonisen J.E. Connett J.P. Kiley Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV-1: The Lung Health Study JAMA 272 1994 1497 1505
3. N.R. Anthonisen J. Manfreda C.R.W. Warren Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease Ann Intern Med 106 1987 196 204
4. N.R. Anthonisen E.C. Wright B. Burrows IPPB Trial Group. Prognosis in chronic obstructive pulmonary disease Am Rev Respir Dis 133 1986 14 20
5. K. Ashutosh M. Dunsky Noninvasive tests for responsiveness of pulmonary hypertension to oxygen. Prediction of survival in patients with chronic obstructive lung disease and cor pulmonale Chest 92 1987 393 399
6. R.J. Barst L.J. Rubin W.A. Long A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension N Engl J Med 334 1996 296 301
7. F. Bassett B. Corrin H. Spencer Pulmonary histiocytosis-X Am Rev Respir Dis 118 1978 811 820
8. S.R. Benatar Fatal asthma N Engl J Med 314 1986 423 429
9. A. Boehler R. Speich E.W. Russi Lung transplantation for lymphangioleiomyomatosis N Engl J Med 335 1996 1275 1280
10. S.S. Braman J.T. Kaemmerlen Intensive care of status asthmaticus: A 10-year experience JAMA 264 1990 366 368
11. F. Brenot Primary pulmonary hypertension. Case series from France Chest 105 1994 33S 36S
12. J.R. Britton Effects of social class, sex, and region of residence on age at death from cystic fibrosis Br Med J 298 1989 483 487
13. J.G.W. Burdon E.F. Juniper K.J. Killian The perception of breathlessness in asthma Am Rev Respir Dis 126 1982 825 828
14. B. Burrows R.H. Earle Course and prognosis of chronic obstructive lung disease N Engl J Med 280 1969 397 404
15. B. Burrows J.W. Bloom G.A. Traver The course and prognosis of different forms of chronic airways obstruction in a sample from the general population N Engl J Med 317 1987 1309 1314
16. C.B. Carrington D.W. Cugell E.A. Gaensler Lymphangioleiomyomatosis Am Rev Respir Dis 116 1977 977 995
17. C.B. Carrington E.A. Gaensler R.E. Coutu Natural and treated course of usual and desquamative interstitial pneumonia N Engl J Med 298 1978 801 809
18. R.M. Cherniak T.V. Colby A. Flint Correlation of structure and function in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 151 1995 1180 1188
19. T.V. Colby C. Lombard Histiocytosis X in the lung Hum Pathol 14 1983 847 856
20. A.F. Connors N.V. Dawson C. Thomas Outcomes following acute exacerbations of severe chronic obstructive lung disease Am J Respir Crit Care Med 154 1996 959 967
21. B. Corrin A.A. Liebow P.J. Friedman Pulmonary lymphangioleiomyomatosis: A review Am J Pathol 79 1975 347 382
22. P.A. Corris J.H. Dark Aetiology of asthma: Lessons from lung transplantation Lancet 341 1993 1369 1371
23. 1 -Antitrypsin deficiency, emphysema, and liver disease: Genetic basis and strategies for therapy J Clin Invest 85 1990 1343 1352
24. R.G. Crystal P.B. Bitterman S.I. Rennard Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract N Engl J Med 310 1884 154 166 235–244
25. R.G. Crystal J.E. Gadek V.J. Ferrans Interstitial lung disease: Current concept of pathogenesis, staging and therapy Am J Med 70 1981 542 568
26. G.R. Cutting L.M. Kasch B.J. Rosenstein Two patients with cystic fibrosis, nonsense mutations in each cystic fibrosis gene, and mild pulmonary disease N Engl J Med 323 1990 1685 1689
27. Cystic Fibrosis Foundation Patient Registry 1995 Annual Data Report 1996 Cystic Fibrosis Foundation Bethesda, MD
28. Cystic Fibrosis Genotype-Phenotype Consortium: Correlation between genotype and phenotype in patients with cystic fibrosis N Engl J Med 329 1993 1308 1313
29. G.E. D'Alonzo R.J. Barst S.M. Ayres Survival in patients with primary pulmonary hypertension Ann Intern Med 115 1991 343 349
30. Dankert-Roelse J.E. G.J. te Meerman Long-term prognosis of patient with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre Thorax 50 1995 712 718
31. D.R. Dantzker G.E. D'Alonzo L. Gianotti Vasodilators and primary pulmonary hypertension. Variability of long-term response Chest 95 1989 1185 1189
32. P.B. Davis M. Drumm M.W. Konstan Cystic fibrosis Am J Respir Crit Care Med 154 1996 1229 1256
33. C.F. Diener B. Burrows Further observations on the course and prognosis of chronic obstructive pulmonary disease Am Rev Respir Dis 111 1975 719 724
34. R.B. Dreisin M.I. Schwarz A.N. Theofilopoulos Circulating immune complexes in the idiopathic interstitial pneumonias N Engl J Med 298 1978 353 357
35. A.H. Eliasson Y.Y. Phillips M.F. Tenholder Treatment of lymphangioleiomyomatosis: A meta-analysis Chest 196 1989 1352 1355
36. G.R. Epler T.C. McLoud E.A. Gaensler Normal chest roentgenograms in chronic diffuse infiltrative lung disease N Engl J Med 298 1978 934 939
37. P. Ernst W.O. Spitzer S. Suissa Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use JAMA 268 1992 3462 3464
38. M. Feinleib H.M. Rosenberg J.G. Collins Trends in COPD morbidity and mortality in the United States Am Rev Respir Dis 140 1989 S9 S18
39. S.C. FitzSimmons The changing epidemiology of cystic fibrosis J Pediatr 122 1993 1 9
40. P.J. Friedman A.E. Leibow J. Sokoloff Eosinophilic granuloma of the lung: Clinical aspects of primary pulmonary histiocytosis-X in the adult Medicine 60 1981 385 396
41. A. Fujii M. Rabinovitch E.C. Matthews A case of spontaneous resolution of idiopathic pulmonary hypertension Br Heart J 46 1981 574 577
42. J.D. Fulmer W.C. Roberts E.R. vonGal Morphologic–physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis J Clin Invest 63 1979 665 676
43. V. Fuster P.M. Steele W.D. Edwards Primary pulmonary hypertension: Natural history and the importance of thrombosis Circulation 70 1984 580 587
44. E.A. Gaensler C.B. Carrington R.E. Coutu Radiographic–physiologic–pathologic correlations in interstitial pneumonias Progress in Respiratory Research 8 1975 223 241
45. E.A. Gaensler A.M. Goff C.M. Prowse Desquamative interstitial pneumonia N Engl J Med 274 1966 113 128
46. K.H. Gan H.J. Veeze A. Van Der Hout A cystic fibrosis mutation associated with mild lung disease N Engl J Med 333 1995 95 99
47. A.R. Glanville C.M. Burke J. Theodore Primary pulmonary hypertension. Length of survival in patients referred for heart–lung transplantation Chest 91 1987 675 681
48. K. Gray-Donald L. Gibbons S.H. Shapiro Nutritional status and mortality in chronic obstructive lung disease Am J Respir Crit Care Med 153 1996 961 966
49. P.L. Haslam C.W.G. Turton A. Lukoszek Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy Thorax 35 1980 328 339
50. M.R. Hetzel T.J.H. Clark M.A. Branthwaite Asthma: Analysis of sudden deaths and ventilatory arrests in hospital Br Med J 1 1977 808 811
51. N. Hiwatari S. Shimura T. Sasaki Prognosis of idiopathic pulmonary fibrosis in patients with mucous hypersecretion Am Rev Respir Dis 143 1991 182 185
52. J.E. Hodgkin Prognosis in chronic obstructive pulmonary disease Clin Chest Med 11 1990 555 569
53. C. Houde D.J. Bohn R.M. Freedom Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators Br Heart J 70 1993 461 468
54. G.W. Hunninghake S. Gilbert R. Pueringer Outcome for treatment for sarcoidosis Am J Respir Crit Care Med 149 1994 893 898
55. 1 -protease inhibitor deficiency Am J Med 84 1988 3 11
56. Intermittent Positive Pressure Trial Group Intermittent positive pressure breathing therapy of chronic obstructive pulmonary disease Ann Intern Med 99 1983 612 620
57. R.E. Kanner A.D. Renzetti Predictors of spirometric changes and mortality in the obstructive airways disorders Chest 85 1984 S15 S18
58. R.E. Kanner A.D. Renzetti W.M. Stanish Predictors of survival in subjects with chronic airflow obstruction Am J Med 74 1983 249 255
59. B.A. Keogh R.G. Crystal Clinical significance of pulmonary function tests in interstitial pulmonary disease What does it tell us? Chest 78 1980 856 865
60. E. Kerem J. Reisman M. Corey Prediction of mortality in patients with cystic fibrosis N Engl J Med 326 1992 1187 1191
61. D. Kerstein P. Levy D.T. Hsu Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension Circulation 91 1995 2028 2035
62. Y. Kikuchi S. Okabe G. Tamura Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma N Engl J Med 330 1994 1329 1334
63. T. King M.I. Schwarz R.E. Dreisin Circulating immune complexes in pulmonary eosinophilic granuloma Ann Intern Med 91 1979 397 399
64. M. Kitaichi K. Nishimura H. Itoh Pulmonary lymphangioleiomyomatosis: A report of 46 patients, including a clinicopathologic study of prognostic factors Am J Respir Crit Care Med 151 1995 527 533
65. Klinger JR, Hill NS: Right ventricular dysfunction in chronic obstructive pulmonary disease: Evaluation and management. Chest 99:715–723
66. R. Kraemer A. Rudeberg B. Hadorn E. Rossi Relative underweight in cystic fibrosis and its prognostic value Acta Paediatr Scand 67 1978 33 37
67. J. Lacronique C. Roth J.P. Battesti Chest radiological features of pulmonary histiocytosis X: A report based on 50 adult cases Thorax 37 1982 104 109
68. M.E. Lahey Histiocytosis X: Comparison of three treatment regimens J Pediatr 87 1975 179 184
69. D.M. Lang M. Polansky Patterns of asthma mortality in Philadelphia from 1969–1991 N Engl J Med 331 1994 1542 1546
70. 1 -antitrypsin deficiency, PiZ Acta Med Scand 204 1978 345 351
71. J. Leatherman Life-threatening asthma Clin Chest Med 15 1994 453 479
72. L.O. Lewin P.J. Byard P.B. Davis Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients J Clin Epidemiol 43 1990 125 131
73. S. Lofgren S.L. Stavenow Course and prognosis of sarcoidosis: Stockholm Am Rev Respir Dis 84 1961 71 73
74. C.M. Lombard L.J. Medeiros T.V. Colby Pulmonary histiocytosis X and carcinoma Arch Pathol Lab Med 111 1987 339 341
75. J. Mana A. Salazar F. Manresa Clinical factors predicting persistence of activity in sarcoidosis: A multivariate analysis of 193 cases Respiration 61 1994 219 225
76. D.W. Mapel J.M. Samet D.B. Coultas Corticosteroids and the treatment of idiopathic pulmonary fibrosis: Past, present and future Chest 110 1996 1058 1067
77. M.S. Marcus S.A. Sondel P.M. Farrell Nutritional status in infants with cystic fibrosis associated with early diagnosis and intervention Am J Clin Nutr 54 1991 578 585
78. C.H. Marquette F. Saulnier O. Leroy Long-term prognosis of near-fatal asthma Am Rev Respir Dis 146 1992 76 81
79. E.R. McFadden R. Kiser W.J. DeGroot Acute bronchial asthma N Engl J Med 288 1973 221 225
80. Medical Research Council Working Party Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema Lancet 1 1981 681 686
81. N.A. Molfino A.S. Slutsky Near-fatal asthma Eur Respir J 7 1994 981 990
82. N.A. Molfino L.J. Nannini A.N. Martelli Respiratory arrest in near-fatal asthma N Engl J Med 324 1991 285 288
83. N.A. Molfino L.J. Nannini A.S. Rebuck The fatality-prone asthmatic patient Chest 101 1992 621 623
84. R.D. Mountain S.A. Sahn Clinical features and outcomes in patients with acute asthma presenting with hypercapnia Am Rev Respir 138 1988 535 539
85. N.L. Mueller R.R. Miller W.R. Webb Fibrosing alveolitis: CT–pathologic correlation Radiology 160 1986 585 588
86. N.L. Mueller C.A. Staples R.R. Miller Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation Radiology 165 1987 731 734
87. E. Neville A.N. Walker D. Geraint James Prognostic factors predicting the outcome of sarcoidosis: An analysis of 818 patients Q J Med 208 1983 525 533
88. M.R. Nihill M.P. O'Laughlin C.E. Mullins Effects of atrial septostomy in patients with terminal cor pulmonale due to pulmonary vascular disease Cathet Cardiovasc Dis 24 1991 166 172
89. J.S. Nine S.A. Yousem I.L. Paradis Lymphangioleiomyomatosis: Recurrence after lung transplantation J Heart Lung Transplant 13 1994 714 719
90. P.A. Nixon D.M. Orenstein S.F. Kelsey The prognostic value of exercise testing in patients with CF N Engl J Med 327 1992 1785 1788
91. Nocturnal Oxygen Therapy Trial Group Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease Ann Intern Med 93 1980 391 398
92. M. Nootens S. Freels E. Kaufmann Timing of single lung transplantation for primary pulmonary hypertension J Heart Lung Transplant 13 1994 276 281
93. B.E. Noyes D.M. Orenstein Treatment of pneumothorax in cystic fibrosis in the era of lung transplantation Chest 101 1992 1187 1188
94. J.D. O'Brien J.H. Lium J.F. Parosa Lymphangioleiomyomatosis recurrence in allograft after single-lung transplantation Am J Respir Crit Care Med 151 1995 2033 2036
95. H. Olschewski D. Walmrath R. Schermuly Aerosolized prostacyclin and iloprost in severe pulmonary hypertension Ann Intern Med 124 1996 820 824
96. M.E. Osband J.M. Lipton P. Lavin Histiocytosis X: Demonstration of abnormal immunity, T-cell histamine H2-receptor deficiency, and successful treatment with thymic extract N Engl J Med 304 1981 146 153
97. M. Oswald-Mammosser E. Weitzenblum E. Quoix Prognostic factors in COPD patients receiving long-term oxygen therapy: Importance of pulmonary artery pressure Chest 107 1995 1193 1198
98. R.J. Panos R.L. Mortenson S.A. Niccoli Clinical deterioration in patients with idiopathic pulmonary fibrosis: Causes and assessment Am J Med 88 1990 396 404
99. Postma DS21 Sluiter H.J. Prognosis of chronic obstructive pulmonary disease: The Dutch experience Am Rev Respir Dis 140 1989 S100 S105
100. D. Prophet Primary pulmonary histiocytosis-X Clin Chest Med 3 1982 643 653
101. J.W. Quinn P.C. Pruitt Eosinophilic granuloma of the lung Diseases of the Chest 38 1960 205 210
102. A.S. Rebuck J. Read Assessment and management of severe asthma Am J Med 51 1971 788 798
103. M. Remy-Jardin F. Giraud J. Remy Pulmonary sarcoidosis: Role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment Radiology 191 1994 675 680
104. A.D. Renzetti J.H. McClement B.D. Litt The Veterans Administration cooperative study of pulmonary function: Mortality in relation to respiratory function in chronic obstructive pulmonary disease Am J Med 41 1966 115 129
105. S. Rich B.H. Brundage P.S. Levy The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension Circulation 71 1985 1191 1196
106. S. Rich E. Kaufmann P.S. Levy The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension N Engl J Med 327 1992 76 81
107. S. Rich D.R. Dantzker S.M. Ayres Primary pulmonary hypertension. A national prospective study Ann Intern Med 107 1987 216 223
108. A.L. Ries R.M. Kaplan T.M. Limberg Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease Ann Intern Med 122 1995 823 832
109. R.J. Risdall L.P. Dehner P. Duray Histiocytosis X (Langerhans' cell histiocytosis): Prognostic role of histopathology Arch Pathol Lab Med 107 1983 59 63
110. A. Rozkovek P. Montanes C.M. Oakley Factors that influence the outcome of primary pulmonary hypertension Br Heart J 55 1986 449 458
111. L.J. Rubin R.J. Barst L.R. Kaiser ACCP consensus statement. Primary pulmonary hypertension Chest 104 1993 236 250
112. C.G. Salvaterra L.J. Rubin Investigation and management of pulmonary hypertension in chronic obstructive pulmonary disease Am Rev Respir Dis 148 1993 1414 1417
113. J. Sandoval O. Bauerle A. Palomar Survival in primary pulmonary hypertension Circulation 89 1994 1733 1744
114. D.A. Schwartz R.A. Helmers J.R. Galvin Determinants of survival in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 149 1994 450 454
115. D.A. Schwartz D.S. Van Fossen C.S. Davis Determinants of progression in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 149 1994 444 449
116. 1 -antitrypsin deficiency Am J Respir Crit Care Med 151 1995 369 373
117. 1 -antitrypsin deficiency Eur Respir J 7 1994 1985 1987
118. L. Sharples T. Hathaway C. Dennis Prognosis of patients with cystic fibrosis awaiting heart and lung transplantation J Heart Lung Transplant 12 1993 669 674
119. L.E. Siltzbach Sarcoidosis clinical features and management Med Clin North Am 51 1967 483 502
120. E.F. Silverstein K. Ellis M. Wolff Pulmonary lymphangioleiomyomatosis Roentgenology 120 1974 832 850
121. M.D. Silverstein C.E. Reed E.J. O'Connell Long-term survival of a cohort of community residents with asthma N Engl J Med 331 1994 1537 1541
122. M. Sly Changing asthma mortality Ann Allergy 73 1994 259 268
123. M. Smith L.J. McCormack H.S. Van Ordstrand Primary pulmonary histiocytosis X Chest 2 1974 176 180
124. M.L. Spector R.C. Stern Pneumothorax in cystic fibrosis: A 26-year experience Ann Thorac Surg 47 1989 204 207
125. B.H.R. Stack Y.J. Choo-Yang B.E. Heard The prognosis of cryptogenic fibrosing alveolitis Thorax 27 1972 535 542
126. W. Stanford C. Spivey E.F. Lindberg Eosinophilic granuloma of the lung Ann Thorac Surg 11 1971 299 304
127. R.C. Stern G. Borkat S.S. Hirschfeld Heart failure in cystic fibrosis American Journal of Diseases of Childhood 134 1980 267 272
128. R.C. Strunk Identification of the fatality-prone subject with asthma J Allergy Clin Immunol 83 1989 477 485
129. R.C. Strunk Death due to asthma: New insights into sudden unexpected deaths, but the focus remains on prevention Am Rev Respir Dis 148 1993 55 552
130. R.C. Strunk D.A. Mrazek G.S. Wolfson Physiologic and psychological characteristics associated with deaths due to asthma in childhood: A case-controlled study JAMA 254 1985 1193 1198
131. L.D. Suarez E.E. Sciandro J.J. Llera Long-term follow-up in primary pulmonary hypertension Br Heart J 41 1979 702 708
132. S. Sur T.B. Crotty G.M. Kephart Sudden-onset fatal asthma: A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa Am Rev Respir Dis 148 1993 713 719
133. N.B. Sweezey K.E. Fellows Bronchial artery embolization for severe hemoptysis in cystic fibrosis Chest 97 1990 1322 1326
134. O.C. Tablan W.J. Martone C.F. Doershuk Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis Chest 91 1987 527 532
135. K. Takada Y. Ina M. Noda The clinical course and prognosis of patients with severe, moderate, or mild sarcoidosis J Clin Epidemiol 46 1993 359 366
136. D.R. Taylor J. Ryu T.V. Colby Lymphangioleiomyomatosis N Engl J Med 323 1990 1254 1260
137. D.R. Taylor M.R. Sears D.W. Cockcroft The β-agonists controversy Med Clin North Am 80 1996 719 748
138. J. Thompson H.A. Buechner R. Fishman Eosinophilic granuloma of the lung Ann Intern Med 48 1958 1134 1145
139. J.F. Tomashefski A. Khiyami J. Kleinerman Neoplasms associated with pulmonary eosinophilic granuloma Arch Pathol Lab Med 115 1991 499 506
140. G.I. Town C. Allan Ventilatory responses to hypoxia and hypercapnia in asthmatics with previous respiratory failure Aust N Z J Med 19 1989 426 430
141. G.A. Traver M.G. Cline B. Burrows Predictors of mortality in chronic obstructive pulmonary disease: A 15-year follow-up study Am Rev Respir Dis 119 1979 895 902
142. L.-C. Tsui Cystic fibrosis transmembrane conductance regulator gene Am J Respir Crit Care Med 151 1995 S47 S53
143. P. Tukianinan E. Taskinen P. Hosti Prognosis of cryptogenic fibrosing alveolitis Thorax 38 1983 349 355
144. M. Turner-Warwick P.L. Haslam The value of serial bronchoalveolar lavages in the clinical progress of patients with cryptogenic fibrosing alveolitis Am Rev Respir Dis 135 1987 26 34
145. M. Turner-Warwick B. Burrows A. Johnson Cryptogenic fibrosing alveolitis: Clinical features and their influence on survival Thorax 35 1980 171 180
146. C.S. Ulrik J. Frederiksen Mortality and markers of risk of asthma death among 1075 outpatients with asthma Chest 108 1995 10 15
147. A. Verstaeten M. Demedts J. Verwilghen Predictive value of bronchoalveolar lavage in pulmonary sarcoidosis Chest 98 1990 560 567
148. K. Viskum J. Vestbo Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiologic stage Eur Respir J 6 1993 349 353
149. K. Viskum J. Vestbo The prognosis of extrapulmonary sarcoidosis Sarcoidosis 11 1994 73 75
150. J.-B. Wasserfallen M.-D. Schaller F. Feihl Sudden asphyxic asthma: A distinct entity? Am Rev Respir Dis 142 1990 108 111
151. L.C. Watters T.E. King M.I. Schwarz A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis Am Rev Respir Dis 133 1986 97 103
152. L.C. Watters M.I. Schwarz R.M. Cherniack Idiopathic pulmonary fibrosis: Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy Am Rev Respir Dis 135 1987 696 704
153. E.K. Weir L.J. Rubin S.M. Ayres The acute administration of vasodilators in primary pulmonary hypertension Am Rev Respir Dis 140 1989 1623 1630
154. A.U. Wells P. Cullinan D.M. Hansell Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than the lone cryptogenic fibrosing alveolitis Am J Respir Crit Care Med 149 1994 1583 1590
155. A.U. Wells D.M. Hansell M.B. Rubens The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis Am Rev Respir Dis 148 1993 1076 1082
156. D.E. Westerman S.R. Benatar P.D. Potgieter Identification of the high-risk asthmatic patient Am J Med 66 1979 565 572
157. A.W. Williams W.G. Dunnington S.J. Berte Pulmonary eosinophilic granuloma: A clinical and pathologic discussion Ann Intern Med 54 1961 30 45
158. T.J. Williams D.V. Tuxen C.D. Scheinkestel Risk factors for morbidity in mechanically ventilated patients with acute severe asthma Am Rev Respir Dis 146 1992 607 615
159. D.O. Wilson D.M. Rogers E.C. Wright Body weight in chronic obstructive pulmonary disease: National Institutes of Health Intermittent Positive Breathing Trial Am Rev Respir Dis 139 1989 1435 1438
160. R.H. Winterbauer S.P. Hammar K.O. Hallman Diffuse interstitial pneumonitis: Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine Am J Med 65 1978 661 672
161. P.H. Wright B.E. Heard S.J. Steel Cryptogenic fibrosing alveolitis: Assessment by graded trephine lung biopsy histology compared with clinical, radiographic, and physiologic features British Journal of Diseases of the Chest 75 1981 61 70
162. 1 -antitrypsin deficiency, PiZZ J Clin Epidemiol 41 1988 1157 1165